Enfield Pharmaceuticals Private LIMITED
Company Profile
ENFIELD PHARMACEUTICALS PRIVATE LIMITED is located at No 5-82/2, Sy No 226/b, Backside Of Society, Rangareddy, Telangana, INDIA. Operating in the Whol drugs/sundries industry.
Enfield Pharmaceuticals Private LIMITED
No 5-82/2, Sy No 226/b, Backside Of Society , 501401, Rangareddy
Corporation
2023
Whol drugs/sundries
Enfield Pharmaceuticals Private LIMITED
No 5-82/2, Sy No 226/b, Backside Of Society , 501401, Rangareddy
Corporation
2023
Whol drugs/sundries
The revenue of Enfield Pharmaceuticals Private LIMITED is $2.5 million
Enfield Pharmaceuticals Private LIMITED: Revenue from 2017 to 2024
Revenue of ENFIELD PHARMACEUTICALS PRIVATE LIMITED: This data presents the revenue of ENFIELD PHARMACEUTICALS PRIVATE LIMITED from 2023 to 2023. In the fiscal year 2023, ENFIELD PHARMACEUTICALS PRIVATE LIMITED recorded a revenue of $2,495,684, showcasing its financial growth over recent years.
Revenue per year in USD ($)
Top 5 companies in revenue in Drugs, Drug Proprietaries, and Druggists' Sundries Worldwide
Company name | Sales |
---|---|
Cencora, Inc. | $262.2 billion |
Cardinal Health, Inc. | $205.0 billion |
McKesson Corporation | $276.7 billion |
PHOENIX Pharmahandel GmbH & Co KG | $38.6 billion |
Pfizer Service Company | $42.4 billion |
The number of employees of Enfield Pharmaceuticals Private LIMITED is 20-49
Enfield Pharmaceuticals Private LIMITED: Employees from 2017 - 2024
Employees at ENFIELD PHARMACEUTICALS PRIVATE LIMITED: ENFIELD PHARMACEUTICALS PRIVATE LIMITED now employs 23 people, reflecting the company’s significant presence.
Number of employees from 2017 to 2024
Global B2B Data in Bulk
Access the company database that sets the standard in scale and accuracy. Our massive B2B database covers all active companies worldwide, curated from trusted local sources. Delivered in bulk as CSV files.
The Industry of Enfield Pharmaceuticals Private LIMITED is Drugs, Drug Proprietaries, and Druggists' Sundries
Enfield Pharmaceuticals Private LIMITED Industry Data:
Industry of ENFIELD PHARMACEUTICALS PRIVATE LIMITED: ENFIELD PHARMACEUTICALS PRIVATE LIMITED operates in the Whol drugs/sundries industry, which falls under SIC Code 5122
Industry Statistics By Sic Code
Enfield Pharmaceuticals Private LIMITED is operating in Sic Code:
Drugs, Drug Proprietaries, and Druggists' Sundries (5122) - Representation of companies operating in Australia/Asia and India
919015
0.26% of companies worldwide
342689
1.22% of companies in INDIA
There are 919015 companies operating in this industry worldwide.
Buy in BulkBold Platform
The Bold platform provides instant access to verified data from active companies in 1,500 industries across 200+ countries, enabling users to find leads and download company lists in Excel.
Enfield Pharmaceuticals Private LIMITED is solely 0 companies Worldwide
Ownership ENFIELD PHARMACEUTICALS PRIVATE LIMITED. ENFIELD PHARMACEUTICALS PRIVATE LIMITED established ownership in 2023 and operates independently with no additional companies in its corporate family structure. Registered as 3, this autonomy enables flexibility for swift decisions and unique strategies.
Company Type
Enfield Pharmaceuticals Private LIMITED is registered as
153647093
44.07% of companies
1678081
5.97% of companies in INDIA
Bold Hierarchy
The Bold platform is your resource for Company Hierarchy Data, featuring insights on all companies connected across 200+ countries. Our database provides essential information about corporate structures, chains, and groups, empowering you to make informed, data-driven decisions.

Connect with Key Decision Makers at Enfield Pharmaceuticals Private LIMITED
Email and Call Top Enfield Pharmaceuticals Private LIMITED Contacts
ENFIELD PHARMACEUTICALS PRIVATE LIMITED has a CEO registered at the official local trade register in INDIA. With 23 key contacts and decision makers, including CIOs, CFOs, and HR managers, ENFIELD PHARMACEUTICALS PRIVATE LIMITED provides high-quality, verified communication with primary decision makers.
Unlock Access to Key Personnel Contact Information on the Bold Platform Today!